Prudential plc’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.6M | Sell |
45,294
-3,983
| -8% | -$782K | 0.05% | 217 |
|
|
2026
Q1 | $9.66M | Hold |
49,277
| – | – | 0.06% | 193 |
|
|
2025
Q4 | $8.55M | Hold |
49,277
| – | – | 0.07% | 219 |
|
|
2025
Q3 | $9.39M | Buy |
49,277
+5,677
| +13% | +$1.01M | 0.07% | 195 |
|
|
2025
Q2 | $7.83M | Sell |
43,600
-23,629
| -35% | -$4.1M | 0.05% | 203 |
|
|
2025
Q1 | $11.4M | Sell |
67,229
-180
| -0.3% | -$29.6K | 0.06% | 163 |
|
|
2024
Q4 | $10.2M | Sell |
67,409
-5,516
| -8% | -$858K | 0.05% | 163 |
|
|
2024
Q3 | $11.3M | Buy |
72,925
+865
| +1% | +$129K | 0.06% | 161 |
|
|
2024
Q2 | $9.86M | Buy |
72,060
+1,300
| +2% | +$178K | 0.07% | 169 |
|
|
2024
Q1 | $9.42M | Buy |
70,760
+32,975
| +87% | +$4.28M | 0.07% | 162 |
|
|
2023
Q4 | $5.21M | Sell |
37,785
-529
| -1% | -$69.5K | 0.05% | 231 |
|
|
2023
Q3 | $4.67M | Buy |
38,314
+13,504
| +54% | +$1.8M | 0.05% | 222 |
|
|
2023
Q2 | $3.49M | Sell |
24,810
-1,410
| -5% | -$194K | 0.04% | 272 |
|
|
2023
Q1 | $3.71M | Sell |
26,220
-1,626
| -6% | -$233K | 0.04% | 252 |
|
|
2022
Q4 | $4.36M | Buy |
27,846
+10,151
| +57% | +$1.46M | 0.05% | 232 |
|
|
2022
Q3 | $2.17M | Sell |
17,695
-6,132
| -26% | -$808K | 0.03% | 274 |
|
|
2022
Q2 | $3.17M | Buy |
23,827
+18,721
| +367% | +$2.55M | 0.06% | 219 |
|
|
2022
Q1 | $699K | Buy |
+5,106
| New | +$712K | 0.01% | 508 |
|
|
2021
Q3 | – | Sell |
-2,751
| Closed | -$363K | – | 483 |
|
|
2021
Q2 | $363K | Sell |
2,751
-5,555
| -67% | -$727K | ﹤0.01% | 468 |
|
|
2021
Q1 | $1.07M | Sell |
8,306
-19,845
| -70% | -$2.45M | 0.01% | 458 |
|
|
2020
Q4 | $3.35M | Sell |
28,151
-1,809
| -6% | -$221K | 0.02% | 327 |
|
|
2020
Q3 | $3.43M | Sell |
29,960
-2,445
| -8% | -$289K | 0.02% | 315 |
|
|
2020
Q2 | $3.69M | Buy |
32,405
+991
| +3% | +$105K | 0.02% | 291 |
|
|
2020
Q1 | $2.52M | Buy |
31,414
+10,447
| +50% | +$1.08M | 0.01% | 316 |
|
|
2019
Q4 | $2.24M | Sell |
20,967
-186,224
| -90% | -$19.4M | 0.01% | 274 |
|
|
2019
Q3 | $22.2M | Buy |
207,191
+179,430
| +646% | +$18.4M | 0.07% | 227 |
|
|
2019
Q2 | $2.83M | Buy |
27,761
+1,317
| +5% | +$127K | 0.01% | 456 |
|
|
2019
Q1 | $2.38M | Buy |
26,444
+3,075
| +13% | +$266K | 0.01% | 396 |
|
|
2018
Q4 | $1.95M | Buy |
23,369
+14,369
| +160% | +$1.35M | 0.01% | 414 |
|
|
2018
Q3 | $971K | Hold |
9,000
| – | – | ﹤0.01% | 488 |
|
|
2018
Q2 | $989K | Buy |
9,000
+800
| +10% | +$83.3K | ﹤0.01% | 500 |
|
|
2018
Q1 | $822K | Sell |
8,200
-1,400
| -15% | -$143K | ﹤0.01% | 515 |
|
|
2017
Q4 | $946K | Sell |
9,600
-1,600
| -14% | -$152K | ﹤0.01% | 510 |
|
|
2017
Q3 | $1.05M | Sell |
11,200
-100
| -0.9% | -$10.6K | ﹤0.01% | 482 |
|
|
2017
Q2 | $1.26M | Hold |
11,300
| – | – | ﹤0.01% | 481 |
|
|
2017
Q1 | $1.11M | Sell |
11,300
-7,250
| -39% | -$691K | ﹤0.01% | 466 |
|
|
2016
Q4 | $1.71M | Buy |
18,550
+500
| +3% | +$43.1K | 0.01% | 436 |
|
|
2016
Q3 | $1.53M | Buy |
18,050
+3,500
| +24% | +$294K | 0.01% | 422 |
|
|
2016
Q2 | $1.19M | Hold |
14,550
| – | – | ﹤0.01% | 438 |
|
|
2016
Q1 | $1.04M | Buy |
14,550
+7,700
| +112% | +$516K | ﹤0.01% | 440 |
|
|
2015
Q4 | $487K | Hold |
6,850
| – | – | ﹤0.01% | 479 |
|
|
2015
Q3 | $421K | Hold |
6,850
| – | – | ﹤0.01% | 449 |
|
|
2015
Q2 | $497K | Sell |
6,850
-6,850
| -50% | -$506K | ﹤0.01% | 448 |
|
|
2015
Q1 | $1.05M | Buy |
+13,700
| New | +$981K | ﹤0.01% | 418 |
|
Other funds holding DGX
EIG
Prudential plc's DGX Position: Q2 2026 in Review
Prudential plc reduced its Quest Diagnostics (DGX) stake by 8.1% in Q2 2026, selling an estimated $782K and leaving 45,294 shares worth $9.6M. The position accounts for 0.05% of the portfolio, ranked #217.
Prudential plc first reported a position in DGX in Q1 2015 and has held it in 44 quarters since. The position peaked at $22.2M in Q3 2019. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Prudential plc held 45,294 shares of Quest Diagnostics worth $9.6M as of Q2 2026.
- Prudential plc sold 3,983 Quest Diagnostics shares in Q2 2026, an estimated $782K.
- Quest Diagnostics made up 0.05% of Prudential plc's portfolio in Q2 2026, its #217 holding.
- Prudential plc first reported a position in Quest Diagnostics in Q1 2015 and has held it in 44 quarters since.
- Prudential plc's Quest Diagnostics position peaked at $22.2M in Q3 2019.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.